K. Sharma et al., Inhibition of type I and IIIIP(3)Rs by TGF-beta is associated with impaired calcium release in mesangial cells, AM J P-REN, 278(6), 2000, pp. F1022-F1029
Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) mediate cytosolic free cal
cium concentration ([Ca2+](c)) signals in response to a variety of agonists
that stimulate mesangial cell contraction and proliferation. In the presen
t study, we demonstrate that mesangial cells express both type I and III IP
(3)Rs and that these receptors occupy different cellular locations. Chronic
treatment with transforming growth factor-beta 1 (TGF-beta 1; 10 ng/ml, 24
h) leads to downregulation of both type I and III IP(3)Rs as measured by i
mmunoblot and confocal analysis. TGF-beta 1 treatment does not affect IP3 l
evels, and downregulation of type I IP3R is not due to enhanced degradation
of the protein, as the half-life of type I IP3R is unchanged in the presen
ce or absence of TGF-beta 1. Functional effects of TGF-beta 1-induced downr
egulation of the IP(3)Rs were evaluated by measuring [Ca2+](c) changes in r
esponse to epidermal growth factor (EGF) in intact cells and sensitivity of
[Ca2+](c) release to IP3 in permeabilized cells. TGF-beta 1 pretreatment l
ed to a significant decrease of [Ca2+](c) release induced by EGF in intact
cells and by submaximal IP3 (400 nm) in permeabilized cells. Total IP3-sens
itive [Ca2+](c) stores were not changed, as assessed by stimulation with ma
ximal doses of IP3 (10.5 mu m) and thapsigargin-mediated calcium release in
permeabilized cells. We conclude that prolonged exposure to TGF-beta 1 lea
ds to downregulation of both type I and III IP(3)Rs in mesangial cells and
this is associated with impaired sensitivity to IP3.